DE:SBS's free cash flow for Q4 2022 was €-18.88M. For the 2022 fiscal year, DE:SBS's free cash flow was decreased by €-51.98M and operating cash flow was €-12.01M. See a summary of the company’s cash flow.

Cash Flow	TTM	Dec 22	Dec 21	Dec 20	Dec 19	Dec 18
Operating Cash Flow	€ 10.28M	€ 10.28M	€ 63.47M	€ 31.85M	€ 21.26M	€ 11.95M
Investing Cash Flow	€ -19.00M	€ -19.00M	€ -20.13M	€ -21.84M	€ -27.72M	€ -10.79M
Financing Cash Flow	€ -14.11M	€ -14.11M	€ -34.33M	€ 5.22M	€ 5.45M	€ -927.00K
Cash Flow From Discontinued Operation	-	-	-	-	-	-
Other Cash Adjustment Inside Changein Cash	-	-	-	-	-	-
End Cash Position	€ 155.44M	€ 22.67M	€ 47.18M	€ 37.56M	€ 22.71M	€ 24.09M
Income Tax Paid Supplemental Data	-	-	-	-	-	-
Interest Paid Supplemental Data	-	-	-	-	-	-
Issuance Of Capital Stock	€ 1.50M	€ 1.74M	€ 1.26M	€ 2.80M	€ 2.01M	€ 1.58M
Issuance Of Debt	€ 2.85M	-	-	€ 32.00M	€ 23.00M	€ 9.00M
Repayment Of Debt	€ -4.84M	-	-	€ -19.48M	€ -9.75M	€ -1.97M
Free Cash Flow	€ -8.74M	€ -8.74M	€ 43.24M	€ 6.27M	€ -5.58M	€ -7.49M
Domestic Sales	-	-	-	-	-	-
Foreign Sales	-	-	-	-	-	-

Currency in EUR

STRATEC Biomedical Cash Flow

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing